サポート ブログ Using Recombinant Antibody Production to Create Antibodies

Using Recombinant Antibody Production to Create Antibodies

Biointron 2024-02-27 Read time: 3 mins
Recombinant-Antibodies.jpg
Image credit: DOI: 10.1007/s00114-002-0400-5

Recombinant antibody production is a revolutionary technology that has significantly impacted biomedical research and therapeutic applications. Unlike traditional antibody generation methods that rely on the immune response in animals, recombinant techniques involve the use of genetic engineering to produce antibodies with high specificity and reproducibility.  

Antibodies, or immunoglobulins, are pivotal to the immune response, recognizing and neutralizing pathogens such as bacteria and viruses. Traditionally, antibodies were produced by immunizing animals and extracting the serum. However, recombinant antibody production bypasses the need for animal immunization, using instead genetically modified cells to produce desired antibodies. 

Recombinant Antibody Production Process 

1. Gene Isolation and Cloning 

The process begins with isolating the gene that encodes the antibody of interest. This gene is then cloned into a vector, a DNA molecule used to transport genetic material into a host cell. 

2. Host Cell Selection and Modification 

Common host cells, including bacteria (E. coli), yeast, and mammalian cells, are genetically modified to incorporate the antibody gene. This modification enables the cells to produce the antibody. 

3. Cultivation and Expression 

The modified host cells are cultivated in bioreactors, where conditions are optimized for cell growth and antibody expression. This stage involves careful control of temperature, pH, and nutrient supply. 

4. Purification and Verification 

Following expression, the antibodies are purified from the culture medium. Techniques such as affinity chromatography ensure the isolation of high-purity antibodies. The specificity and activity of the antibodies are then verified through various assays. 

Advantages of Recombinant Antibody Production 

Recombinant antibodies offer several advantages over traditional methods, including higher specificity, the ability to produce antibodies against a wide range of antigens, and improved reproducibility. They can also be engineered to enhance their therapeutic efficacy. Recombinant antibodies have diverse applications, from therapeutic agents in the treatment of cancer, autoimmune diseases, and infections to diagnostic tools in medical research and clinical diagnostics.

Subscribe to our ブログ

Recent ブログ

Antibody specificity refers to an antibody's ability to selectively bind to a unique epitope on a target antigen while avoiding interactions with unrelated antigens. This property arises from the highly specialized antigen-binding site located in the variable region of the antibody, which determines its unique binding characteristics.

Dec 20, 2024
ブログ

Antibody affinity refers to the strength of the binding interaction between a single antigen epitope and the paratope (binding site) of an antibody. This interaction is a fundamental measure of how well an antibody recognizes its specific antigen target.

Dec 20, 2024
ブログ

Recombinant antibodies are produced using genetic engineering techniques, unlike traditional antibody production, where the immune system generates antibodies without direct control over their sequence. By introducing genes encoding antibody fragments into host cells, such as bacteria or mammalian cells, recombinant antibodies can be expressed, purified, and deployed for applications including research, diagnostics, and therapeutics.

Dec 19, 2024
ブログ

Recombinant antibody expression is a biotechnological process that involves engineering and producing antibodies outside their natural context using recombinant DNA technology.

Dec 19, 2024
ブログ

お客様の利便性を向上させるためにクッキーを使用しています。詳しくは プライバシーポリシー をご覧ください。